Search - tctmd.com

Displaying 861 - 880 of 1550

Sort: Relevancy | Date

News Daily News

Another Observational Study Supports Role for Genotype-Guided Antiplatelet Choices Post-PCI

Yael L. Maxwell

April 04, 2018

News Daily News

Respiratory Syncytial Virus Linked With Cardiovascular Complications

Michael O'Riordan

April 04, 2018

News Daily News

Unplanned Readmissions Within 30 Days Post-PCI Affect Nearly One in 10 US Patients

L.A. McKeown

April 04, 2018

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for March 2018

Shelley Wood

April 02, 2018

News Daily News

Videos Boost Oral and Written Explanations to Help Patients Understand PCI

L.A. McKeown

March 29, 2018

Podcast Heart Sounds

Varenicline Boosts Long-term Quit Rate in Post-ACS Smokers: EVITA

Caitlin E. Cox

March 26, 2018

News Daily News

Coronary Procedures After TAVR: New Practical Guide Reviews Tools, Techniques

Yael L. Maxwell

March 23, 2018

News Daily News

No Increase in Long-term Cardiac Mortality After PCI for Women Compared With Men

L.A. McKeown

March 21, 2018

News Conference News ACC 2018

High CRP Linked to Bigger Absolute Drops in CV Events for Patients Taking Evolocumab

Michael O'Riordan

March 20, 2018

News Conference News ACC 2018

Loading Dose Smooths Switch From Ticagrelor to Clopidogrel After PCI: SWAP-4

Yael L. Maxwell

March 19, 2018

News Conference News ACC 2018

PHARMCLO: Biggest Genotyping Trial to Date Suggests Better Outcomes After ACS, With Caveats

Yael L. Maxwell

March 14, 2018

News Daily News

For CHD Patients, Physical Activity More Meaningful Than Weight Changes Over Time

Caitlin E. Cox

March 13, 2018

News Conference News ACC 2018

Too Soon for 6-Month DAPT, Say SMART-DATE Investigators, Despite Positive Trial

Yael L. Maxwell

March 12, 2018

ACC 2018, Day Three: Gout, Hypertension, and Diabetes Dominate Opening Late Breaker

News Conference News ACC 2018

ACC 2018, Day Three: Gout, Hypertension, Diabetes, PFO Closure, DAPT, NOAC Reversal, and More

Shelley Wood

March 12, 2018

News Conference News ACC 2018

SECURE-PCI Comes Up Short for Statin Preloading in ACS Patients

Michael O'Riordan

March 11, 2018

News Conference News ACC 2018

TREAT: No Major Bleeds With Ticagrelor in ACS Patients After Fibrinolysis

Shelley Wood

March 11, 2018

News Conference News ACC 2018

Genetic Testing Influences Post-PCI Antiplatelet Prescriptions, but Other Factors Also Play a Role

Yael L. Maxwell

March 11, 2018

News Conference News ACC 2018

Reducing Co-payments for P2Y12 Inhibitors Upped Ticagrelor Use but Didn’t Budge MACE: ARTEMIS

Caitlin E. Cox

March 11, 2018

Presentation ACC 2018

Uptake and Utilization of Drug-Eluting Bioresorbable Vascular Scaffolds: A CathPCI Registry Study

Presenter: Ajay J. Kirtane

March 11, 2018

Advertisement

Another Observational Study Supports Role for Genotype-Guided Antiplatelet Choices Post-PCI

Respiratory Syncytial Virus Linked With Cardiovascular Complications

Unplanned Readmissions Within 30 Days Post-PCI Affect Nearly One in 10 US Patients

TCTMD’s Top 10 Most Popular Stories for March 2018

Videos Boost Oral and Written Explanations to Help Patients Understand PCI

Top Stories in Cardiology, March 2018

Varenicline Boosts Long-term Quit Rate in Post-ACS Smokers: EVITA

Coronary Procedures After TAVR: New Practical Guide Reviews Tools, Techniques

No Increase in Long-term Cardiac Mortality After PCI for Women Compared With Men

High CRP Linked to Bigger Absolute Drops in CV Events for Patients Taking Evolocumab

Loading Dose Smooths Switch From Ticagrelor to Clopidogrel After PCI: SWAP-4

PHARMCLO: Biggest Genotyping Trial to Date Suggests Better Outcomes After ACS, With Caveats

For CHD Patients, Physical Activity More Meaningful Than Weight Changes Over Time

Too Soon for 6-Month DAPT, Say SMART-DATE Investigators, Despite Positive Trial

ACC 2018, Day Three: Gout, Hypertension, Diabetes, PFO Closure, DAPT, NOAC Reversal, and More

SECURE-PCI Comes Up Short for Statin Preloading in ACS Patients

TREAT: No Major Bleeds With Ticagrelor in ACS Patients After Fibrinolysis

Genetic Testing Influences Post-PCI Antiplatelet Prescriptions, but Other Factors Also Play a Role

Reducing Co-payments for P2Y12 Inhibitors Upped Ticagrelor Use but Didn’t Budge MACE: ARTEMIS

Uptake and Utilization of Drug-Eluting Bioresorbable Vascular Scaffolds: A CathPCI Registry Study

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content